Zhao WL - Search Results

1

Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma.

Wang Y, Shi Q, Shi ZY, Tian S, Zhang MC, Shen R, Fu D, Dong L, Yi HM, Ouyang BS, Mu RJ, Cheng S, Wang L, Xu PP, Zhao WL. Wang Y, et al. Among authors: zhao wl. Blood Adv. 2024 Apr 9;8(7):1587-1599. doi: 10.1182/bloodadvances.2023011425. Blood Adv. 2024. PMID: 38170757 Free PMC article.

2

Rituximab plus CHOP (R-CHOP) overcomes PRDM1-associated resistance to chemotherapy in patients with diffuse large B-cell lymphoma.

Liu YY, Leboeuf C, Shi JY, Li JM, Wang L, Shen Y, Garcia JF, Shen ZX, Chen Z, Janin A, Chen SJ, Zhao WL. Liu YY, et al. Among authors: zhao wl. Blood. 2007 Jul 1;110(1):339-44. doi: 10.1182/blood-2006-09-049189. Epub 2007 Mar 22. Blood. 2007. PMID: 17379744 Free article.

3

[Expression of tumor suppressor gene PRDM1 in lung cancers].

Liu YY, Yang SJ, Ma J, Wang L, Liu YH, Chen SJ, Shen ZX, Zhao WL. Liu YY, et al. Among authors: zhao wl. Zhonghua Zhong Liu Za Zhi. 2007 Jun;29(6):434-6. Zhonghua Zhong Liu Za Zhi. 2007. PMID: 17974277 Chinese.

4

PRDM1 is involved in chemoresistance of T-cell lymphoma and down-regulated by the proteasome inhibitor.

Zhao WL, Liu YY, Zhang QL, Wang L, Leboeuf C, Zhang YW, Ma J, Garcia JF, Song YP, Li JM, Shen ZX, Chen Z, Janin A, Chen SJ. Zhao WL, et al. Blood. 2008 Apr 1;111(7):3867-71. doi: 10.1182/blood-2007-08-108654. Epub 2008 Jan 30. Blood. 2008. PMID: 18235046 Free article.

5

[Analysis of overexpression of vascular endothelial growth factor-C in patients with angioimmunoblastic T-cell lymphoma].

Zhao WL, Liu YY, Plassa F, Jin XL, Wang L, Janin A, Shen ZX. Zhao WL, et al. Zhonghua Xue Ye Xue Za Zhi. 2007 Oct;28(10):664-6. Zhonghua Xue Ye Xue Za Zhi. 2007. PMID: 18399170 Chinese.

6

The prognostic value of immunohistochemical subtyping in Chinese patients with de novo diffuse large B-cell lymphoma undergoing CHOP or R-CHOP treatment.

Xia ZG, Xu ZZ, Zhao WL, Zhao SQ, Ding F, Chen Y, Chen QS, Zheng Y, Zhu Q, Hu JP, Shen ZX, Li JM. Xia ZG, et al. Among authors: zhao wl, zhao sq. Ann Hematol. 2010 Feb;89(2):171-7. doi: 10.1007/s00277-009-0799-2. Epub 2009 Aug 11. Ann Hematol. 2010. PMID: 19669764

7

Proteasome inhibitor bortezomib targeted tumor-endothelial cell interaction in T-cell leukemia/lymphoma.

Shi WY, Wang L, Xiao D, Yao Y, Yang F, Jiang XX, Leboeuf C, Janin A, Chen SJ, Zhao WL. Shi WY, et al. Among authors: zhao wl. Ann Hematol. 2011 Jan;90(1):53-8. doi: 10.1007/s00277-010-1022-1. Epub 2010 Jul 9. Ann Hematol. 2011. PMID: 20617436

8

Cytostatic and anti-angiogenic effects of temsirolimus in refractory mantle cell lymphoma.

Wang L, Shi WY, Wu ZY, Varna M, Wang AH, Zhou L, Chen L, Shen ZX, Lu H, Zhao WL, Janin A. Wang L, et al. Among authors: zhao wl. J Hematol Oncol. 2010 Sep 9;3:30. doi: 10.1186/1756-8722-3-30. J Hematol Oncol. 2010. PMID: 20828385 Free PMC article.

9

Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patients.

Xu PP, Wang Y, Shen Y, Wang L, Shen ZX, Zhao WL. Xu PP, et al. Among authors: zhao wl. Med Oncol. 2012 Sep;29(3):2176-82. doi: 10.1007/s12032-011-0011-0. Epub 2011 Jun 28. Med Oncol. 2012. PMID: 21710236

10

[Prognostic analysis of non-cytogenetic factors in elderly adults with acute myeloid leukemia].

Zhao BB, Zhu Z, Xu PP, Li JM, Shen ZX, Zhao WL, Wang L. Zhao BB, et al. Among authors: zhao wl. Zhonghua Xue Ye Xue Za Zhi. 2013 Jan;34(1):3-7. Zhonghua Xue Ye Xue Za Zhi. 2013. PMID: 23597455 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

405 results

Search Page

Filters